EUVIMEDEUVIMED entdecken
Crossref

The association between glycaemic control, normal weight and long‐term macrovascular outcomes in people with type 2 diabetes in China: A retrospective study

Feng Sun iD, Meng Zhang, Qi Pan iD, Peng Shen, Yexiang Sun, Hongbo Lin, Siyan Zhan iD, Lixin Guo iD

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.70237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Feng Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glycemic Control, Diabetic Angiopathies, Cardiovascular Diseases. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Eli Lilly and Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To investigate associations between glycaemic control and normal body mass index (BMI) and the long‐term risk of 3‐point major adverse cardiovascular events (3P‐MACE) in patients with type 2 diabetes (T2D). Materials and Methods Adults with T2D and ≥1 glycated haemoglobin (HbA1c) and BMI record between 1 January 2007 and 31 October 2016 were included from the regional health information system of Yinzhou district, Ningbo, China. The index population comprised patients with HbA1c records ≥3 months after the initial T2D diagnosis and BMI records after the initial T2D diagnosis. Of these, patients with ≥1 BMI record after the index date were included in the sustained population. Analyses were conducted using Cox proportional hazards models.

Results

The index population included 5757 patients (median follow‐up 6.8 years; 1188 [20.6%] experienced 3P‐MACE). In this population, the 3P‐MACE risk was significantly reduced in patients with glycaemic control and normal BMI (18.5–23.9 kg/m 2 ) versus neither glycaemic control nor normal BMI using HbA1c cutoffs of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Glycemic ControlDiabetic AngiopathiesCardiovascular DiseasesHumansFemaleMaleMiddle AgedChinaRetrospective StudiesBody Mass IndexGlycated HemoglobinAgedBlood GlucoseAdultRisk Factors

Stichwörter der Autor:innen

cardiovascular eventsglycaemic controlmacrovascular diseasereal world studytype 2 diabetesweight management

Substanzen

Glycated HemoglobinBlood Glucosehemoglobin A1c protein, human

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, China.
  • Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China.
  • Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • Yinzhou District Center for Disease Control and Prevention, Ningbo City, Zhejiang Province, China.

ORCID-Profile: Feng Sun, Qi Pan, Siyan Zhan, Lixin Guo

Förderung

  • Eli Lilly and Company

Zitieren

APA

Sun, F., Zhang, M., Pan, Q., Shen, P., Sun, Y., Lin, H., Zhan, S., & Guo, L. (2026). The association between glycaemic control, normal weight and long‐term macrovascular outcomes in people with type 2 diabetes in China: A retrospective study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70237

Vancouver

Sun F, Zhang M, Pan Q, Shen P, Sun Y, Lin H, et al. The association between glycaemic control, normal weight and long‐term macrovascular outcomes in people with type 2 diabetes in China: A retrospective study. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70237

BibTeX
@article{Sun2026,
  author = {Sun, Feng and Zhang, Meng and Pan, Qi and Shen, Peng and Sun, Yexiang and Lin, Hongbo and Zhan, Siyan and Guo, Lixin},
  title = {The association between glycaemic control, normal weight and long‐term macrovascular outcomes in people with type 2 diabetes in China: A retrospective study},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70237}
}
Kostenlos starten →